Related Experiment Video
Updated: Mar 18, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice
Agustina Roldan-Deamicis1, Eliana Alonso2, Belén Brie1
1Instituto de Investigaciones Biomédicas, Facultad de Ciencias Medicas, Pontificia Universidad Católica Argentina - UCA - CONICET, Buenos Aires, Argentina.
Abstract:
The understanding of the molecular mechanisms of the immune tolerance induced by the tumoral microenvironment is fundamental to prevent cancer development or to treat cancer patients using immunotherapy. Actually, there are investigations about "addressed-drugs" against cancer cells without affecting normal cells. It could be ideal to find selective and specific compounds that only recognize and destroy tumor cells without damaging the host normal cells. For thousands of years, mushrooms have been used for medicinal purposes because of their curative properties. D-Fraction, an extract of Maitake (from the edible Grifola frondosa mushroom), rich in β-glucans, exert notable effects in the immune system. Until now, some published articles suggest that Maitake D-Fraction could have anti-tumoral activity, prevent oncogenesis and metastasis in some tumor types. However, there are no clear data about Maitake D-Fraction action on breast cancer prevention and its exact molecular mechanisms are not yet elucidated. The experiments were performed employing 25 female BALBc mice that were treated with and without Maitake D-Fraction Pro4X or Maitake Standard for 15 days by daily intraperitoneal injection. After treatment period, all mice were implanted with murine tumor cells LM3 to induce mammary tumorigenesis. Animals were checked weekly and killed after 46 days of LM3 transplant; percentage of cancer prevention, rate of tumor growing, and overall survival were determined. Under dissection, the internal organs were evaluated histologically and genetically by RT-PCR. We found that 5 mg/kg per day of Maitake D-Fraction Pro4X, administered dairy during 15 days to BALBc mice was able to block more than 60% breast cancer development. However, Maitake Standard prevents oncogenesis in 26% to respect control. In this work, we found that Maitake D-Fraction Pro4X, administered to BALBc mice, prevents breast carcinogenesis, block tumor invasiveness, reduce angiogenesis, and increase overall survival.
Insights
Maitake D-Fraction Pro4X significantly blocked over 60% of breast cancer development in mice. This mushroom extract also reduced tumor invasiveness, angiogenesis, and improved survival, offering potential for breast cancer prevention.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Tumor microenvironment's role in immune tolerance is crucial for cancer development and immunotherapy.
- Targeted therapies aim to destroy cancer cells selectively, sparing normal cells.
- Maitake mushroom extract (D-Fraction), rich in β-glucans, shows potential immune-modulating and anti-tumoral effects.
Purpose of the Study:
- To investigate the efficacy of Maitake D-Fraction Pro4X in preventing breast cancer.
- To elucidate the molecular mechanisms underlying Maitake D-Fraction's anti-cancer effects.
- To evaluate Maitake D-Fraction's impact on tumor invasiveness, angiogenesis, and survival.
Main Methods:
- Female BALBc mice were treated with Maitake D-Fraction Pro4X or Maitake Standard.
- Mammary tumorigenesis was induced by implanting LM3 tumor cells.
- Cancer prevention, tumor growth, survival rates, and histological/genetic analyses were assessed.
Main Results:
- Maitake D-Fraction Pro4X blocked over 60% of breast cancer development.
- Maitake Standard showed 26% oncogenesis prevention compared to controls.
- Maitake D-Fraction Pro4X reduced tumor invasiveness and angiogenesis, and increased overall survival.
Conclusions:
- Maitake D-Fraction Pro4X demonstrates significant potential in preventing breast cancer development in a mouse model.
- The extract effectively inhibits tumor invasiveness and angiogenesis.
- Further research into Maitake D-Fraction's molecular mechanisms could lead to novel breast cancer therapies.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study

